OverviewSuggest Edit
Quest Diagnostics is the world's leading provider of diagnostic testing, information, and services that patients and doctors need to make better healthcare decisions. The Company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, interpretive consultation through its extensive medical and scientific staff, cancer diagnostics, and anatomic pathology services.
Quest Diagnostics's wide range of products and services benefit patients, healthcare providers, and pharmaceutical medical device companies, life insurance companies, and employers.
| Type | Public | |
| Founded | 1967 | |
| HQ | Madison, US | Map |
| Website | questdiagnostics.com | |
| Employee Ratings | More |
Recent NewsAll News
- Quest Diagnostics Prices $500 Million of Senior Notes
- Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
- RMC and Quest Diagnostics to Deliver High-Value, Innovative Lab Services
- Quest Diagnostics Partners With Houston Healthcare to Deliver High-Value, Innovative Laboratory Services
Key People/Management at Quest Diagnostics
Stephen H. Rusckowski
Quest Diagnostics Office Locations
Quest Diagnostics Financials and Metrics
Quest Diagnostics Revenue
| USD | |
|---|---|
Revenue (FY, 2018) | 7.5b |
Gross profit (FY, 2018) | 2.6b |
Gross profit margin (FY, 2018), % | 34.6% |
Net income (FY, 2018) | 788.0m |
EBIT (FY, 2018) | 1.1b |
Market capitalization (18-Mar-2019) | 11.9b |
Closing stock price (18-Mar-2019) | 88.7 |
Cash (31-Dec-2018) | 135.0m |
EV | 15.7b |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.8b | 1.7b | 1.9b | 1.9b | 1.8b | 1.9b | 1.9b | 1.9b | 1.9b | 1.9b | 1.9b | 1.9b | 1.9b | 1.9b | 3.8b | 1.9b |
Cost of goods sold | 1.1b | 1.1b | 1.2b | 1.2b | 1.2b | 1.2b | 1.2b | 1.1b | 1.2b | 1.2b | 1.2b | 1.2b | 1.2b | 1.2b | 2.5b | 1.2b |
Gross profit | 698.6m | 645.0m | 728.0m | 726.0m | 676.0m | 743.0m | 718.0m | 719.0m | 751.0m | 728.0m | 734.0m | 773.0m | 741.0m | 658.0m | 1.3b | 667.0m |
Gross profit Margin, % | 39% | 37% | 38% | 38% | 37% | 39% | 38% | 39% | 39% | 39% | 39% | 40% | 38% | 35% | 35% | 35% |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 158.3m | 144.0m | 144.0m | 170.0m | 974.0m | 150.0m | 123.0m | 128.0m | 283.0m | 406.0m | 367.0m | 314.0m | 350.0m | 124.0m | 132.0m | 263.0m |
Inventories | 85.2m | 99.0m | 109.0m | 111.0m | 106.0m | 109.0m | 86.0m | 82.0m | 80.0m | 82.0m | 77.0m | 83.0m | 100.0m | 94.0m | 91.0m | 95.0m |
Current Assets | 1.4b | 1.5b | 1.5b | 1.6b | 2.4b | 1.5b | 1.6b | 1.5b | 1.5b | 1.6b | 1.6b | 1.5b | 1.5b | 1.4b | 1.4b | 1.6b |
PP&E | 749.4m | 851.0m | 884.0m | 888.0m | 902.0m | 906.0m | 886.0m | 925.0m | 937.0m | 952.0m | 1.0b | 1.0b | 1.1b | 1.2b | 1.2b | 1.2b |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 732.1m | 111.0m | 253.0m | 392.0m | 70.0m | 199.0m | 553.0m | 114.0m | 324.0m | 529.0m | 175.0m | 382.0m | 557.0m | 189.0m | 422.0m | 649.0m |
Depreciation and Amortization | 211.0m | 75.0m | 156.0m | 235.0m | 78.0m | 153.0m | 230.0m | 62.0m | 123.0m | 186.0m | 62.0m | 128.0m | 197.0m | 74.0m | 151.0m | 228.0m |
Accounts Payable | (76.8m) | (86.0m) | (39.0m) | 20.0m | (120.0m) | (49.0m) | (41.0m) | (77.0m) | 23.0m | 43.0m | (95.0m) | (93.0m) | (3.0m) | (68.0m) | (64.0m) | 51.0m |
Cash From Operating Activities | 441.6m | 84.0m | 364.0m | 635.0m | 52.0m | 327.0m | 539.0m | 143.0m | 464.0m | 765.0m | 196.0m | 490.0m | 852.0m | 180.0m | 503.0m | 905.0m |
| USD | Y, 2018 |
|---|---|
EV/EBIT | 14.2 x |
EV/CFO | 13.1 x |
EV/FCF | 19.2 x |
Revenue/Employee | 165.5k |
Financial Leverage | 2.1 x |
Quest Diagnostics Operating Metrics
| FY, 2016 | |
|---|---|
Accounts | 250 k |
Patents Issued | 700 |
Patents Pending | 570 |
Patient Service Centers | 2.20 k |
Quest Diagnostics Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| California Laboratory Associates | October 30, 2017 | |
| Cleveland HeartLab | October 18, 2017 | |
| Cape Cod Healthcare - Business | June 28, 2017 | |
| ClearPoint Diagnostic | June 12, 2017 | |
| Med fusion | June 12, 2017 | |
| PeaceHealth Laboratories | February 15, 2017 |
Quest Diagnostics Revenue Breakdown
Quest Diagnostics revenue breakdown by business segment: 95.6% from Diagnostic Information Services and 4.4% from Other
Quest Diagnostics Online and Social Media Presence
8.55k Twitter followers
Quest Diagnostics has 8.55k Twitter Followers. The number of followers has increased 1% month over month and increased 3.6% quarter over quarter
Twitter Engagement Stats for @QuestDX
7.6k
Tweets
601
Following
8.5k
Followers
108
Tweets last 30 days
1.1
Avg. likes per Tweet
39.8%
Tweets with engagement
Quest Diagnostics News and Updates
Quest Diagnostics Prices $500 Million of Senior Notes
Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
RMC and Quest Diagnostics to Deliver High-Value, Innovative Lab Services
Quest Diagnostics Partners With Houston Healthcare to Deliver High-Value, Innovative Laboratory Services
Quest Diagnostics Elects Denise Morrison to Board of Directors
Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019
Quest Diagnostics Blogs
Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories
Workforce Drug Positivity Rises by Double-Digits in Almost One-Third of U.S. Industry Sectors Examined, According to New Quest Diagnostics Analysis
Aetna and Ascension Join Five Other Leading Health Care Companies in Blockchain-Driven Effort to Address Health Care Provider Data Issues
Quest Diagnostics to Acquire the Laboratory Services Business of Boyce and Bynum Pathology Laboratories, Expanding Diagnostic Innovation in the Midwest
Quest Diagnostics to accelerate cardiovascular disease biomarker discovery as part of One Brave Idea™ initiative to end coronary heart disease
Quest Diagnostics Frequently Asked Questions
When was Quest Diagnostics founded?
Quest Diagnostics was founded in 1967.
Who are Quest Diagnostics key executives?
Quest Diagnostics's key executives are Stephen H. Rusckowski.
How many employees does Quest Diagnostics have?
Quest Diagnostics has 46,000 employees.
What is Quest Diagnostics revenue?
Latest Quest Diagnostics annual revenue is $7.5 b.
What is Quest Diagnostics revenue per employee?
Latest Quest Diagnostics revenue per employee is $163.7 k.
Who are Quest Diagnostics competitors?
Competitors of Quest Diagnostics include Laboratory Corporation of America Holdings, Thermo Fisher Scientific and Angle.
Where is Quest Diagnostics headquarters?
Quest Diagnostics headquarters is located at Giralda Farms, Madison.
Where are Quest Diagnostics offices?
Quest Diagnostics has offices in Madison, Secaucus, Vega Alta, Barceloneta and in 6 other locations.
How many offices does Quest Diagnostics have?
Quest Diagnostics has 12 offices.